D5 1/2 NS (dextrose 5% in 0.45% sodium chloride) is not listed as a compatible solution for Zosyn (piperacillin/tazobactam) in the manufacturer’s prescribing information. The FDA-approved labeling specifies a short list of approved diluents and infusion solutions, and D5 1/2 NS does not appear on it.
What the Manufacturer Lists as Compatible
The official prescribing information approved by the FDA lists the following solutions as compatible for reconstituting and further diluting Zosyn:
- 0.9% sodium chloride for injection (normal saline)
- Sterile water for injection
- Dextrose 5% (D5W)
- Dextran 6% in saline
Lactated Ringer’s solution is also listed, but only for co-administration through a Y-site and only with the reformulated version of Zosyn that contains EDTA.
That is the complete list. D5 1/2 NS, D5LR, and other common maintenance fluids are absent. The labeling explicitly states that Zosyn is not chemically stable in solutions that significantly alter its pH, and it should not be added to solutions containing only sodium bicarbonate, blood products, or albumin hydrolysates.
Why D5 1/2 NS Is Not Approved
Piperacillin, the active penicillin component in Zosyn, degrades faster when the pH of the surrounding solution shifts outside its stable range. Each IV fluid has a slightly different pH and chemical composition. The manufacturer only guarantees stability and potency in the specific solutions it has tested. Because D5 1/2 NS was not included in those stability studies, there is no official data confirming that Zosyn maintains its full potency or remains free of harmful breakdown products in that fluid.
D5W (dextrose 5% in water) and normal saline (0.9% sodium chloride) are each individually compatible. That does not mean their combination with half-normal saline automatically qualifies. The mixture creates a different chemical environment that has simply not been validated by the manufacturer.
Y-Site Administration
If the question is whether Zosyn can run through the same IV line as a D5 1/2 NS maintenance drip using a Y-site connector, the prescribing information does not address this combination either. The labeling’s Y-site compatibility data is limited to Lactated Ringer’s (EDTA formulation only) and two aminoglycosides (amikacin and gentamicin) at specific concentration ranges in either normal saline or D5W.
The manufacturer states plainly that Zosyn should not be mixed with other drugs in a syringe or infusion bottle since compatibility has not been established. For Y-site scenarios not covered in the labeling, hospital pharmacies typically consult extended compatibility references such as Trissel’s or King Guide, which contain data from independent studies beyond what the package insert includes.
What to Use Instead
The safest approach is to dilute Zosyn in one of the three most commonly used approved solutions: normal saline, D5W, or sterile water for injection. Most hospitals default to normal saline or D5W for the infusion bag. If a patient is receiving D5 1/2 NS as a maintenance fluid on the same IV line, standard practice is to pause the maintenance fluid during the Zosyn infusion or run Zosyn through a separate lumen or dedicated line.
Zosyn is typically infused over 30 minutes for standard dosing (or up to 4 hours for extended-infusion protocols), so the interruption to a maintenance drip is brief. Your facility’s pharmacy can confirm the preferred workflow based on the specific Zosyn formulation stocked, since compatibility details differ between the EDTA-containing reformulation, the original formulation without EDTA, and the premixed Galaxy containers.